Literature DB >> 11219189

CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumonia.

I de Werra1, G Zanetti, C Jaccard, R Chioléro, M D Schaller, B Yersin, M P Glauser, T Calandra, D Heumann.   

Abstract

OBJECTIVES: In patients with septic shock, circulating monocytes become refractory to stimulation with microbial products. Whether this hyporesponsive state is induced by infection or is related to shock is unknown. To address this question, we measured TNF alpha production by monocytes or by whole blood obtained from healthy volunteers (controls), from patients with septic shock, from patients with severe infection (bacterial pneumonia) without shock, and from patients with cardiogenic shock without infection. MEASUREMENTS: The numbers of circulating monocytes, of CD14+ monocytes, and the expression of monocyte CD14 and the LPS receptor, were assessed by flow cytometry. Monocytes or whole blood were stimulated with lipopolysaccharide endotoxin (LPS), heat-killed Escherichia coli or Staphylococcus aureus, and TNF alpha production was measured by bioassay.
RESULTS: The number of circulating monocytes, of CD14+ monocytes, and the monocyte CD14 expression were significantly lower in patients with septic shock than in controls, in patients with bacterial pneumonia or in those with cardiogenic shock (p < 0.001). Monocytes or whole blood of patients with septic shock exhibited a profound deficiency of TNF alpha production in response to all stimuli (p < 0.05 compared to controls). Whole blood of patients with cardiogenic shock also exhibited this defect (p < 0.05 compared to controls), although to a lesser extent, despite normal monocyte counts and normal CD14 expression.
CONCLUSIONS: Unlike patients with bacterial pneumonia, patients with septic or cardiogenic shock display profoundly defective TNF alpha production in response to a broad range of infectious stimuli. Thus, down-regulation of cytokine production appears to occur in patients with systemic, but not localised, albeit severe, infections and also in patients with non-infectious circulatory failure. Whilst depletion of monocytes and reduced monocyte CD14 expression are likely to be critical components of the hyporesponsiveness observed in patients with septic shock, other as yet unidentified factors are at work in this group and in patients with cardiogenic shock.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11219189     DOI: 2001/03/smw-05883

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  5 in total

1.  Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.

Authors:  R Prondzinsky; S Unverzagt; H Lemm; N Wegener; K Heinroth; U Buerke; M Fiedler; J Thiery; J Haerting; K Werdan; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-07-20       Impact factor: 0.840

2.  Optimization of protein solubilization for the analysis of the CD14 human monocyte membrane proteome using LC-MS/MS.

Authors:  Xiaoying Ye; Donald J Johann; Ramin M Hakami; Zhen Xiao; Zhaojing Meng; Robert G Ulrich; Haleem J Issaq; Timothy D Veenstra; Josip Blonder
Journal:  J Proteomics       Date:  2009-08-24       Impact factor: 4.044

3.  Monocyte Tumor Necrosis Factor-α-Converting Enzyme Catalytic Activity and Substrate Shedding in Sepsis and Noninfectious Systemic Inflammation.

Authors:  David J P O'Callaghan; Kieran P O'Dea; Alasdair J Scott; Masao Takata; Anthony C Gordon
Journal:  Crit Care Med       Date:  2015-07       Impact factor: 7.598

4.  Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome.

Authors:  Nikolaos Antonakos; Thomas Tsaganos; Volker Oberle; Iraklis Tsangaris; Malvina Lada; Aikaterini Pistiki; Nikolaos Machairas; Maria Souli; Michael Bauer; Evangelos J Giamarellos-Bourboulis
Journal:  Crit Care       Date:  2017-03-09       Impact factor: 9.097

5.  Concurrent Immune Suppression and Hyperinflammation in Patients With Community-Acquired Pneumonia.

Authors:  Xanthe Brands; Bastiaan W Haak; Augustijn M Klarenbeek; Natasja A Otto; Daniël R Faber; René Lutter; Brendon P Scicluna; W Joost Wiersinga; Tom van der Poll
Journal:  Front Immunol       Date:  2020-05-06       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.